Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PT Triyasa Nagamas Farma is an Indonesian pharmaceutical company founded in 1991 that specializes in the development, manufacturing, and marketing of generic and over-the-counter (OTC) medications. The company operates a manufacturing facility in the Jababeka Industrial Estate in Cikarang, which is certified under Indonesian Good Manufacturing Practices (CPOB). Its product portfolio spans a wide range of therapeutic areas, including anti-infectives, analgesics, gastrointestinal treatments, and nutritional supplements. Triyasa Nagamas Farma focuses on providing high-quality, affordable healthcare solutions to meet the needs of the Indonesian domestic market. The company serves various healthcare segments, including hospitals, pharmacies, and government health programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Triyasa Nagamas Farma.